Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis company. The Company is engaged in the production of medical and recreational cannabis. It is licensed to cultivate and sell dried, extract, edible and topical cannabis. The Company is also engaged in scientific research and the development of products and services, with patient safety as a guiding principle. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho).


CSE:THC - Post by User

Bullboard Posts
Comment by uncleblackieon Nov 27, 2019 7:30pm
72 Views
Post# 30400171

RE:RE:RE:Much less than the average price reported

RE:RE:RE:Much less than the average price reportedWell, yes the but the underyling issue that causes them to be proud of that statement is that retail cannabis is going to be a race to the bottom as far as margins go so yes they are already a low cost producer and the pre rollies will offer good margin for now but will not sustain the company long term imo and edibles will suffer the same margin fate once the market is flooded in a couple of years. The only stable and sustainable margins for now are in medi mary jane, both domestic and export.

There will be a big consolidation that will begin taking place in the industry in probably in less than three years and if they move their asses quickly and get enough good distribution channels in place within that time frame before the margins disappear, they may end up looking like a good buy out candidate.



Bullboard Posts